This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in schizophrenia has been slow, and patients are often left with few options — but pharmas contribute to a robust lineup of candidates that could improve care.
Discover how pharmacies can tackle today's most pressing financial challenges head-on. Our white paper uncovers the financial strain of Direct and Indirect Remuneration (DIR) fees and offers solutions through smarter purchasing. Learn how to minimize fees, ensure compliance and boost efficiency. Don't let fees weigh you down.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Positive results from the FLOW trial demonstrate the potential for Ozempic to become the first GLP-1 treatment option for people living with type 2 diabetes and chronic kidney disease.
On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County , an adult who had contracted the virus abroad had been in health-related settings in Dearborn on two days last week — two urgent care clinics, a CVS pharmacy, and a hospital emergency department. Health officials in neighboring Washtenaw County issued a similar alert about a different case — also an adult, also infected abroad —
Micro and nanoplastics, tiny pieces of plastic scattered throughout the environment, have been increasingly found to be able to enter the body, raising questions about where they end up and how they affect people’s health. In a new study, researchers say they have for the first time detected these plastic pieces inside fatty plaques that accumulate in blood vessels and linked them to an increased rate of heart problems.
Findings emphasize the importance of further research on effective and safe alternative treatments for MDD in children and adolescents, specifically in patients who are refractory to nonpharmacologic treatment and/or standard of care antidepressants
One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall. | One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday. While the current program will eventually allow Medicare to negotiate the prices of up to 20 drugs per year, Biden will propose increasing that number to 50, and bringing more drugs into the negotiation process sooner.
This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.
What makes for good public health guidance? That’s the conversation I was having with a colleague in her 40s railing against the Centers for Disease Control and Prevention’s erstwhile guidance about alcohol consumption for women of “childbearing” years. The guidance, if followed closely, would mean that all women ages 15 to 49 should fully abstain from alcohol consumption unless they’re using birth control.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems, but new owner Oracle plans to close the gap with cloud services from supply chain management to claims processing, a top Oracle Health executive tells STAT. Epic and Cerner have long been in a head-to-head race for medical software contracts. The playing field changed in 2022 when Cerner merged with cloud titan Oracle , coinciding with a loss in its large health system customers in the U.S
The device conducts blood biomarker tests that accurately diagnose amyloid pathology and can assist in diagnosing Alzheimer disease in patients with cognitive impairment.
Millions of cancer screenings were missed during the COVID-19 pandemic. | Cancer is the second leading cause of death in the U.S. As providers try to get more patients into preventive screenings, they lean on patient engagement tools to reach them.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Federal regulators are weighing new safeguards against exploitative dealmaking by private equity firms within healthcare—and, so far, they aren't signaling any reprieve for the corporate investors | FTC, DOJ and HHS heads were receptive to testimonies given by providers and researchers Tuesday on the need for policy changes addressing private equity practices within the healthcare industry.
San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis. Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.
AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. | AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country.
Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient.
Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer biomarker development.
Looking to automate your literature search and review process in pharmacovigilance? Learn how AI can streamline the detection and analysis of Adverse Events (AE) effectively.
Headspace, which has built a growing digital health business around mindfulness, is joining forces with Meta to launch a meditation app for Quest, the social media giant’s virtual reality headset. Called Headspace XR, the newly launched VR app — developed with funding from Meta — guides users through meditation and other activities, like a Tai Chi-inspired movement game, meant to encourage mental wellbeing.
A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector. AZ is preparing to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development and manufacturing of vaccines, including the construction of a new plant that will be powered by renewable energy, according to a government statement.
Pittsburgh-based UPMC, a 40-hospital system, has reported a 2023 operating loss of $198.3 million (-0.7% operating margin) on r | Pittsburgh-based UPMC, a 40-hospital system, has reported a 2023 operating loss of $198.3 million on revenue of $27.7 billion.
NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the UK will depend on a patient’s address.
Ariceum Therapeutics has opened its new laboratory facilities at its Berlin headquarters. This allows in-house R&D for its next generation radiopharmaceutical pipeline candidates and support in the transfer of advancing products into the clinic. There is over ~200m² of laboratory space (cold biology/chemistry lab; radioactive lab) at the new site.
Sandoz has claimed the first FDA approvals for biosimilars of Amgen’s blockbuster bone disease therapy denosumab, but has not said when it plans to launch them onto the US market.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content